SEOUL, Mar. 15 (Korea Bizwire) – The South Korean government is gearing up to disclose a report by year-end that will reveal the financial benefits received by doctors from pharmaceutical companies, sparking a debate on whether to include identifiable information such as names in the report. According to a statement from the Ministry of Health and [...]
SEOUL, Feb. 29 (Korea Bizwire) – Amid a worldwide shake-up of industrial sectors, Korean firms are experiencing a range of emotions about the future of their key operations, feelings that vary widely depending on the size of the business and the industry it belongs to. A recent survey conducted by the Korea Chamber of Commerce and [...]
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (Korea Bizwire) – Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB), a special purpose acquisition company (“Atlantic Coastal”), today announced the filing of [...]
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (Korea Bizwire) – Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies’ [...]
PARIS, Nov. 16, 2023 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® (INN: Piflufolastat (18F) also known as (18 F)-DCFPyL, indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions [...]
SHANGHAI, China, Nov. 07, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development. (November 8-10, 2023) Novotech is commencing this significant summit [...]
SEOUL, Oct. 30 (Korea Bizwire) – The pharmaceutical and biotechnology industry is making significant strides in enhancing its presence in the beauty sector, particularly in the realm of cosmetics. Industry experts suggest that this strategic shift is aimed at attracting consumers and driving sales by emphasizing pharmaceutical companies’ focus on health. In recent developments, the Yuhan [...]
SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]
SEOUL, May 8 (Korea Bizwire) — Pharmaceutical and biotech companies in South Korea are teaming up to develop new drugs using artificial intelligence (AI). During the drug development process, AI can predict whether a chemical compound is suitable for human use, thereby speeding up the identification of potential substances and enabling the selection of appropriate [...]
SEOUL, Aug. 30 (Korea Bizwire) — South Korea’s pharmaceutical and biomedical companies are doubling down on nanomedicine-related investment and research efforts. The Life Science Fund, created jointly by Samsung C&T Corp. and Samsung Biologics Co., decided to invest 19 billion won (US$14 million) in U.S.-based biotech firm Senda Biosciences Inc. last week. Senda possesses the [...]